Full-Time

Qualification Specialist

Posted on 9/23/2025

AdaptHealth

AdaptHealth

1,001-5,000 employees

Home medical equipment provider with rentals

No salary listed

Rochester, NY, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • High school diploma or equivalent required
  • Associate’s degree in healthcare administration, Business Administration, or related field preferred
  • Previous experience in healthcare, insurance, medical billing, or patient services preferred
  • Knowledge of respiratory therapy or DME services preferred
  • Specialist Level: (Entry Level): One (1) year of work-related experience
  • Senior Level: One (1) year of work-related experience plus Two (2) years exact job experience
  • Lead Level: One (1) year of work-related experience plus Four (4) years exact job experience
Responsibilities
  • Evaluate patient medical records, physician orders, and clinical documentation to determine eligibility for DME, PAP, and oxygen therapy equipment
  • Verify patient insurance benefits, coverage limitations, and prior authorization requirements for prescribed medical equipment
  • Analyze physician orders, sleep studies, pulmonary function tests, and other clinical documentation to ensure compliance with coverage criteria
  • Ensure all qualification activities comply with Medicare Local Coverage Determinations (LCDs), National Coverage Determinations (NCDs), and commercial insurance policies
  • Collaborate with physicians, respiratory therapists, discharge planners, and clinical staff to gather necessary documentation and clinical information
  • Contact patients to gather additional medical information, explain coverage requirements, and communicate qualification decisions
  • Monitor authorization status, track approval timelines, and manage reauthorization processes for ongoing therapy requirements
  • Prepare and submit appeals for denied authorizations, including compilation of additional clinical evidence and peer-to-peer review coordination
  • Conduct internal quality reviews of qualification decisions and documentation to ensure accuracy and compliance
  • Utilize patient management systems, insurance portals, and electronic health records to process qualifications and maintain accurate records
  • Identify opportunities to streamline qualification processes, reduce approval times, and improve patient satisfaction while maintaining compliance with all regulatory requirements
  • Maintains patient confidentiality and functions within the guidelines of HIPAA
  • Completes assigned compliance training and other education programs as required
  • Maintains compliance with AdaptHealth's Compliance Program
  • Performs other related duties as assigned
Desired Qualifications
  • Knowledge of Medicare/Medicaid guidelines, commercial insurance policies, medical necessity criteria, and DME/respiratory equipment coverage requirements with relevant experience
  • Understanding of Local Coverage Determinations (LCDs), National Coverage Determinations (NCDs), HIPAA requirements, and healthcare compliance standards with ability to interpret complex coverage policies
  • Familiarity with respiratory conditions, sleep disorders, medical terminology, diagnostic procedures, and treatment protocols related to DME and oxygen therapy services
  • Strong critical thinking, diligence, problem-solving abilities, and capacity to evaluate complex medical and insurance information accurately and efficiently
  • Excellent written and verbal communication skills with professional demeanor for patient interactions and ability to coordinate effectively with healthcare providers and insurance representatives
  • Advanced skills in patient management systems, insurance portals, electronic health records, Microsoft Office Suite, and ability to learn new software applications quickly
  • High ethical standards, integrity in handling confidential information, patience and empathy when collaborating with patients, and commitment to ensuring appropriate patient access to care
  • Ability to work independently with strong organizational skills while collaborating effectively with clinical and operational teams to achieve patient care objectives

AdaptHealth provides home medical equipment and related services to support patients living outside of hospitals. It sells and rents devices such as wheelchairs, ventilators, CPAP machines, thermometers, pulse oximeters, and sanitizing equipment, and also offers resupply and ongoing support; equipment is delivered, installed, maintained, and restocked as needed. The company serves patients, healthcare professionals, and insurance companies by coordinating direct sales, rentals, and insurance partnerships to ensure continuous home-based care. Its goal is to empower patients to live life at home with accessible, coordinated equipment and care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Phoenixville, Pennsylvania

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $819.8M with 9.1% organic growth, raised 2026 guidance to $3.5B.
  • $1.1B credit facility in April 2026 extends maturities to 2031, cuts debt costs 25bps.
  • WellSpan Medical Equipment acquisition effective June 1 bolsters Pennsylvania presence.

What critics are saying

  • Lincare erodes 35% sleep share by diverting 15-20% capitated patients within 6-12 months.
  • CMS prior authorization delays reimbursements 60-90 days, inflating $50M receivables in 3-6 months.
  • Q1 2026 GAAP losses breach $1.1B facility covenants if leverage tops 4.5x within 12-24 months.

What makes AdaptHealth unique

  • AdaptHealth leads with AI-powered order processing pilots launched in 2025.
  • Nationwide 680-location network serves 4.2 million patients across 50 states.
  • Largest patient transition history via 10 million-member capitated contract.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Stock Titan
Apr 13th, 2026
AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs.

AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs. Filing Impact Filing Sentiment Rhea-AI Filing summary. AdaptHealth Corp. entered into a new senior secured credit facility totaling $1.1 billion, replacing its prior credit arrangements and extending its debt maturity profile. The package includes a $325 million Term Loan A, a $325 million delayed draw term loan, and a $450 million revolving credit facility. Proceeds from the new term loan repaid the existing term loan and prior credit agreement, while the delayed draw facility is intended to redeem the 6.125% Senior Notes due 2028, lowering interest expense. The facility, maturing in April 2031, features lower SOFR-based pricing tied to leverage covenants and is supported by recent credit rating upgrades. The company states the transaction does not change its full-year 2026 guidance. Positive. * The new $1.1 billion senior secured credit facility extends AdaptHealth's debt maturity to April 2031, reduces SOFR-based pricing margins, and is expected to lower weighted average cost of debt by at least 25 bps after redemption of the 6.125% Senior Notes due 2028. Negative. Insights. Refinancing extends debt maturities to 2031 and modestly lowers borrowing costs. AdaptHealth has arranged a $1.1 billion senior secured credit facility, combining a term loan, delayed draw term loan, and revolver. This replaces its prior term loan and smaller revolver, consolidating bank debt under a single agreement with standardized covenants. The company plans to use the $325 million delayed draw term loan to redeem its 6.125% Senior Notes due 2028, once callable at par, which should reduce interest expense. The facility matures in April 2031, roughly two years later than the prior structure, easing near-term refinancing risk. Pricing is now indexed to the Consolidated Total Leverage Ratio, with SOFR margins as low as 1.125%. Management estimates at least a 25 bps reduction in weighted average cost of debt after note redemption. Recent rating upgrades by S&P and Moody's likely supported these terms, and the company indicates its 2026 guidance remains unchanged, framing this as a balance-sheet optimization rather than a shift in operating outlook. 8-K event classification. 5 items: 1.01, 1.02, 2.03, 7.01, 9.01 Key figures. Total new credit facility: $1.1 billion Term Loan A size: $325 million Delayed Draw Term Loan: $325 million +5 more Key terms. Delayed Draw Term Loan, Revolving loan commitments, Consolidated Total Leverage Ratio, Term SOFR, +2 more 04/13/2026 - 08:11 AM Faq. What did AdaptHealth (AHCO) announce regarding its new credit facility? AdaptHealth closed a new $1.1 billion senior secured credit facility. It includes a $325 million Term Loan A, a $325 million Delayed Draw Term Loan, and a $450 million revolving credit facility, replacing its prior term loan and smaller revolver. How will AdaptHealth use the proceeds from the new Term Loan A and Delayed Draw Facility? The $325 million Term Loan A was used to fully repay the company's existing term loan and prior credit agreement. The $325 million Delayed Draw Facility is intended to redeem the 6.125% Senior Notes due 2028 once they become callable at par in August 2026. How does the new AdaptHealth credit facility affect debt maturities? The new senior secured credit facility matures in April 2031, extending AdaptHealth's debt maturity profile by roughly two years. This longer runway reduces near-term refinancing risk and supports the company's ability to pursue its strategic and operational priorities. What interest rate terms apply to AdaptHealth's new credit facility? Borrowings can be based on a base rate or Term SOFR, plus an Applicable Margin. For SOFR loans, the margin ranges from 1.125% to 2.000% per year, determined by the Consolidated Total Leverage Ratio, replacing the company's prior, higher pricing grid. Will AdaptHealth's new financing change its 2026 financial guidance? AdaptHealth states the new $1.1 billion credit facility is not expected to affect its full-year 2026 guidance. Management frames the transaction as a refinancing that improves terms and flexibility, rather than a change in the company's underlying operating outlook. What role did credit rating upgrades play in AdaptHealth's new facility? Recent rating upgrades by S&P Global Ratings and Moody's Ratings recognized improved performance and a stronger balance sheet. AdaptHealth believes these upgrades, plus consistent free cash flow, helped secure a lower pricing grid and favorable terms on the new credit facility. Filing exhibits & attachments. 2 documents Press releases.

MarketScreener
Apr 13th, 2026
AdaptHealth secures $1.1B credit facility with extended maturity to 2031 and 25bps lower debt cost

AdaptHealth Corp., a US provider of home medical equipment and services, has closed a $1.1 billion senior secured credit facility, consisting of a $325 million term loan, a $325 million delayed draw facility and a $450 million revolving credit line. The new facility replaces the company's existing debt arrangements. The refinancing extends AdaptHealth's debt maturity to April 2031, approximately two years beyond the previous facility, whilst reducing borrowing costs. The interest rate pricing grid has been lowered, with the lowest tier falling from 1.50% to 1.125% over SOFR. The company expects its weighted average cost of debt to decrease by at least 25 basis points once its 6.125% senior notes due 2028 are redeemed. The improved terms follow recent credit rating upgrades from S&P Global Ratings and Moody's Ratings.

Investing.com
Mar 31st, 2026
OEP entities purchase $4.4M in AdaptHealth shares at $9.81-$9.95

Entities associated with One Equity Partners have acquired $4.4 million worth of AdaptHealth Corp shares across two transactions. On 19 March 2026, the entities purchased 727 shares at $9.94 per share, followed by 447,100 shares at $9.91 per share on 20 March 2026. The purchases occurred at prices ranging from $9.81 to $9.95. Following these transactions, OEP entities now hold 16,312,698 shares of AdaptHealth. The stock currently trades at $11.29, up nearly 9% over the past week. The transactions come after AdaptHealth reported fourth-quarter 2025 earnings that missed EPS expectations but exceeded revenue forecasts at $846.3 million. RBC Capital maintains an Outperform rating with a $13 price target, whilst Leerink Partners lowered its target to $12.

Yahoo Finance
Feb 24th, 2026
AdaptHealth posts $3.2B revenue with new capitated contract expected to drive 5%-6% growth in 2026

AdaptHealth reported 2025 net revenue of $3.245 billion, down 0.5% on a reported basis but up 1.7% organically, with adjusted EBITDA of $616.7 million representing a 19.0% margin. Full-year free cash flow reached $219.4 million, exceeding guidance. The company launched a new operating model that improved setup times and deployed technology pilots including AI-powered order processing. It went live early on a major capitated contract covering approximately 50,000 members across three Mid-Atlantic states, which management expects could ultimately serve 10 million patients and contribute 5%-6% growth in 2026. For 2026, AdaptHealth guided net revenue of $3.44-3.51 billion, adjusted EBITDA of $680-730 million, and free cash flow of $175-225 million. The company ended 2025 with net debt of $1.694 billion and net leverage of 2.75x.

LebTown
May 14th, 2025
WellSpan Health sells durable medical equipment business to AdaptHealth

WellSpan Health has sold its durable medical equipment business, WellSpan Medical Equipment, to national firm AdaptHealth, effective June 1.

INACTIVE